What Happened Before Penicillin? How Antibiotics Changed Modern Medicine

 

Introduction — Before Penicillin

Today, a bacterial infection can often be treated with antibiotics prescribed by a doctor. Medicines such as penicillin and other antibiotics have become an important part of modern healthcare. But before antibiotics became available, many bacterial infections were far more difficult to treat.

A cut, wound, or surgical infection could sometimes develop into a serious illness. Pneumonia and other bacterial diseases could become life-threatening because doctors had very few medicines that could directly stop the bacteria responsible for the infection. Medical care could include cleaning wounds, using antiseptics, providing supportive care, and relying on the body's own immune defenses. Some earlier antimicrobial treatments existed, but they did not provide the broad and reliable treatment options that modern antibiotics would later offer.

The story began to change in 1928, when Scottish bacteriologist Alexander Fleming noticed something unusual in his laboratory. A mould had accidentally contaminated a culture plate containing Staphylococcus bacteria. Around the mould, the bacteria were no longer growing. Fleming investigated the phenomenon and identified a substance produced by the mould that could inhibit bacterial growth. He named it penicillin.

But discovering penicillin was only the beginning. It took more than a decade of further scientific work to turn Fleming's observation into a usable medicine. Researchers including Howard Florey and Ernst Boris Chain helped develop methods to produce and purify penicillin, eventually making large-scale treatment possible.

The story of penicillin is therefore more than the story of one laboratory discovery. It is a story of how an unexpected observation, further scientific research, and large-scale cooperation helped transform the treatment of bacterial infections—and changed modern medicine.

What Did People Do Before Penicillin?

The path to modern antibiotics was gradual: antiseptic surgery developed in the nineteenth century, penicillin was discovered in 1928, and sulfonamide drugs emerged in the 1930s. Penicillin then moved from a laboratory discovery toward practical medical use in the early 1940s.

Before penicillin became widely available, doctors did have ways to prevent and manage infections, but their options were much more limited than they are today.

One important approach was antisepsis. As scientists gradually understood that microorganisms could cause infection, doctors began using antiseptic methods to reduce the number of harmful microorganisms around wounds and during medical procedures. In the nineteenth century, Joseph Lister helped establish antiseptic techniques in surgery, building on the developing understanding of microorganisms and infection.

Wound care was also important. Doctors and nurses cleaned wounds, removed damaged tissue when necessary, and tried to prevent contamination. Supportive care could help the body fight an infection, but these measures could not directly eliminate many bacterial infections once they had become established.

There were also earlier attempts to use substances with antimicrobial properties. Some historical remedies used natural materials, and by the late nineteenth and early twentieth centuries, scientists were beginning to develop more systematic chemical treatments for infectious diseases. However, many of these treatments had significant limitations and were effective against only certain infections.

A major step came in the 1930s with the development of sulfonamide drugs, often called sulfa drugs. These were among the first widely useful antibacterial medicines and were used to treat serious infections, including some forms of pneumonia and other bacterial diseases. Their arrival showed that it was possible to use medicines inside the body to target bacterial infections.

These developments created an important foundation for what came next. By the 1930s, scientists were increasingly searching for substances that could stop harmful bacteria without causing unacceptable harm to patients. This growing effort to find effective antibacterial medicines helped create the scientific environment in which penicillin could move from an unexpected laboratory observation toward a practical treatment.

So, the world was not completely without treatments before penicillin. Instead, medicine was gradually moving toward a new era in which doctors could use increasingly effective drugs to fight bacterial infections directly.

Penicillin would become one of the most important breakthroughs in that transition.

The 1928 Discovery

In 1928, Alexander Fleming was studying bacteria at St. Mary's Hospital in London. During his research, he noticed something unusual on a culture plate containing Staphylococcus bacteria.

A mould had accidentally grown on the plate. Around the mould was a clear area where the bacteria were not growing normally. Instead of ignoring the unexpected contamination, Fleming investigated it more closely.

He identified the mould as belonging to the genus Penicillium and found that it produced a substance capable of inhibiting the growth of certain bacteria. Fleming called this substance penicillin, after the mould that produced it. He published his findings in 1929.

The discovery was scientifically important, but penicillin did not immediately become a widely available medicine. The substance was unstable and difficult to produce and purify in useful quantities. Fleming's observation therefore represented the beginning of a much longer process rather than the finished antibiotic treatment familiar today.

More than a decade later, researchers at Oxford, led by Howard Florey and Ernst Boris Chain, returned to the problem. Their team developed methods for producing and studying penicillin and demonstrated its potential as a treatment for bacterial infections. In 1940, their work showed that penicillin could act as a chemotherapeutic agent in living organisms, helping move the discovery toward practical medical use.

In 1945, Fleming, Florey, and Chain were jointly awarded the Nobel Prize in Physiology or Medicine for the discovery of penicillin and its curative effect in various infectious diseases.

The story illustrates an important lesson in science: a major breakthrough may begin with an unexpected observation, but turning that observation into a useful treatment can require years of additional research, experimentation, and collaboration.

Why the Discovery Wasn't the End of the Story

Alexander Fleming's discovery was remarkable, but discovering penicillin and turning it into a medicine were two very different challenges.

One major problem was that penicillin was difficult to obtain in a stable and sufficiently concentrated form. Fleming's early experiments showed that the substance could inhibit bacteria, but producing enough of it for routine medical treatment was not straightforward.

This is where the work of Howard Florey, Ernst Boris Chain, and their colleagues became especially important. Beginning in the late 1930s, the Oxford research team investigated how penicillin could be extracted, purified, tested, and produced in larger quantities. Their research helped demonstrate that penicillin could be used to treat bacterial infections in patients. (nobelprize.org)

The development of penicillin accelerated during World War II. Scientists and manufacturers in Britain and the United States worked on improving production methods and increasing the amount of penicillin that could be made. By the middle of the 1940s, penicillin was being produced on a much larger scale and had become an important treatment for bacterial infections. (nobelprize.org)

This part of the story is easy to overlook. The famous image of Fleming discovering penicillin in a laboratory captures only the beginning. The transformation of that discovery into a widely useful medicine required many years of laboratory research, clinical testing, industrial development, and international cooperation.

Penicillin therefore became a powerful example of how scientific discoveries can move from an unexpected observation to a practical medical breakthrough—but only through sustained work beyond the original discovery.

How Penicillin Changed Medicine

The arrival of penicillin marked a major change in the treatment of bacterial infections. For the first time, doctors had a powerful antibacterial medicine that could be used to treat a range of serious infections that had previously been difficult to manage.

Penicillin proved effective against infections caused by susceptible bacteria, including certain forms of pneumonia, meningitis, wound infections, and bloodstream infections. It was also highly effective against syphilis and several other bacterial diseases. Its usefulness helped establish antibiotics as an essential part of modern medical practice.

The impact went beyond treating individual infections. Effective antibiotics made many medical procedures safer because doctors could better prevent or treat bacterial infections that might otherwise complicate treatment. Surgery, childbirth, and the care of seriously injured patients all benefited from the growing ability to control bacterial infections.

Penicillin also helped demonstrate the potential of a broader approach to infectious disease: using medicines that specifically target microorganisms rather than relying mainly on the body's natural defenses and supportive treatment.

Its success encouraged researchers to search for additional antibacterial drugs. Over the following decades, many other classes of antibiotics were discovered or developed, expanding the ability of doctors to treat different bacterial infections.

Penicillin was therefore not simply another medicine. It helped open the modern antibiotic era, changing how doctors approached bacterial disease and becoming part of the foundation on which much of modern medicine was built.

How We Benefit Today

The impact of antibiotics can be seen in many parts of modern healthcare. When a bacterial infection is susceptible to an antibiotic, treatment can help the body control the infection and reduce the risk of serious complications. Antibiotics remain especially important for treating potentially life-threatening bacterial infections.

Their benefits extend beyond treating infections that occur on their own. Modern healthcare often depends on being able to prevent or control bacterial infections around medical procedures. Effective antibiotics help reduce the risks associated with major surgery and are an important part of care for some patients receiving treatments such as cancer chemotherapy or organ transplantation, when infections can become especially dangerous.

Antibiotics have also changed what doctors can reasonably do when treating serious illness. Procedures that carry a risk of bacterial infection can be performed with greater protection against infectious complications than would have been possible when effective antibacterial medicines were unavailable.

However, antibiotics are not a treatment for every infection. They work against bacteria, not viruses. Colds, influenza, and many other common viral illnesses do not improve because of antibiotics. Using an antibiotic when it is not needed can expose a person to unnecessary side effects and can contribute to the development of antibiotic resistance.

This makes the legacy of penicillin especially important. The discovery did not simply give doctors one useful medicine; it helped open the way to a much larger field of antibacterial treatment. Today, antibiotics remain one of the essential tools of modern medicine—but their effectiveness depends on using them carefully and appropriately.

The story therefore comes full circle. Before penicillin, doctors had limited ways to directly treat many serious bacterial infections. Today, effective antibiotics can often turn those infections into treatable medical conditions. Protecting that ability is now one of the major challenges facing modern medicine.

The New Challenge: Antibiotic Resistance

The success of antibiotics created a new challenge: bacteria can gradually develop resistance to the medicines designed to stop them.

Antibiotic resistance occurs when bacteria change or acquire characteristics that allow them to survive exposure to antibiotics that would normally kill them or stop their growth. Resistant bacteria can continue to multiply and may spread to other people, making infections more difficult to treat.

Resistance is a natural process, but human use of antibiotics can accelerate it. When antibiotics are used unnecessarily, used incorrectly, or used in ways that expose bacteria to the drugs without effectively controlling the infection, resistant bacteria can have an opportunity to survive and spread. The inappropriate use and overuse of antibiotics are important drivers of antibiotic resistance.

The problem is already measurable on a global scale. According to the World Health Organization's 2025 global surveillance report, approximately one in six laboratory-confirmed bacterial infections causing common infections worldwide was resistant to antibiotic treatment in 2023. WHO also found that resistance increased in more than 40% of the pathogen-antibiotic combinations it monitored between 2018 and 2023.

Antibiotic resistance matters because modern medicine depends on effective antibiotics not only for treating infections, but also for protecting patients during many medical procedures. When infections become resistant to available medicines, treatment can become more complicated, more expensive, and sometimes unsuccessful. Resistant infections can also increase hospital stays and the need for additional treatment.

This does not mean that antibiotics are becoming useless. They remain essential medicines and can save lives when used appropriately. The challenge is to preserve their effectiveness by using them when they are medically appropriate, preventing infections where possible, improving infection control, and continuing research into new treatments and diagnostic tools.

The history of penicillin therefore has an important lesson for the present. Discovering antibiotics changed medicine, but keeping those medicines effective requires careful use and continued scientific effort. The next chapter of the antibiotic story is not simply about discovering more drugs—it is also about protecting the ones that still work.

Final Thoughts

The story of penicillin is a reminder that medical progress rarely happens through a single moment alone.

Before effective antibiotics became available, doctors relied heavily on prevention, antiseptic techniques, wound care, surgery, supportive treatment, and the body's own ability to fight infection. The development of sulfonamide drugs in the 1930s began to change that picture, but the discovery of penicillin opened the way to a much broader era of antibacterial treatment.

Alexander Fleming's observation in 1928 was an important starting point. Yet turning that observation into a practical medicine required years of additional research by scientists including Howard Florey, Ernst Boris Chain, and their colleagues, followed by advances in large-scale production.

The result was a fundamental change in medicine. Antibiotics gave doctors powerful tools for treating bacterial infections and helped make many areas of modern healthcare safer. Their benefits are still part of everyday medical practice today.

But the story is not finished. Antibiotic resistance reminds us that scientific breakthroughs cannot simply be taken for granted. Bacteria can adapt, and the continued effectiveness of antibiotics depends on responsible use, infection prevention, surveillance, and ongoing scientific research.

From an unexpected mould on a laboratory culture plate to medicines used around the world, the history of penicillin shows how observation, research, collaboration, and persistence can transform an idea into a medical breakthrough.

And perhaps that is the most important lesson: medical progress is not only about discovering new treatments—it is also about understanding how to preserve their benefits for the future.

 

Sources & Further Reading

This article draws on information from established medical, scientific, and historical sources. The following resources provide further information about the history of penicillin, early antibacterial medicines, antibiotic use, and antimicrobial resistance.

• Nobel Prize — The 1945 Nobel Prize in Physiology or Medicine: Information on Alexander Fleming, Howard Florey, and Ernst Boris Chain and their contributions to penicillin.
• World Health Organization (WHO) — Global antibiotic resistance surveillance report 2025: Current global data and trends on antibiotic resistance.
• U.S. Centers for Disease Control and Prevention (CDC) — Antibiotic Use and Antimicrobial Resistance: Guidance and evidence on appropriate antibiotic use and the distinction between bacterial and viral infections.
• National Center for Biotechnology Information (NCBI Bookshelf) — History of Antibacterial Drugs: Historical information on sulfonamides and the development of antibacterial treatment.
• PubMed/PMC — Historical research on antiseptic surgery and Joseph Lister: Background on the development of antisepsis and infection prevention before the antibiotic era.

These sources are provided for readers who want to explore the subject further and to distinguish established historical and medical evidence from simplified popular accounts of the penicillin story.